141 related articles for article (PubMed ID: 36183057)
1. Care pathways at end-of-life for cancer decedents: registry based analyses of the living situation, healthcare utilization and costs for all cancer decedents in Norway in 2009-2013 during their last 6 months of life.
Bjørnelv G; Hagen TP; Forma L; Aas E
BMC Health Serv Res; 2022 Oct; 22(1):1221. PubMed ID: 36183057
[TBL] [Abstract][Full Text] [Related]
2. Till death do us part: the effect of marital status on health care utilization and costs at end-of-life. A register study on all colorectal cancer decedents in Norway between 2009 and 2013.
Bjørnelv GMW; Edwin B; Fretland ÅA; Deb P; Aas E
BMC Health Serv Res; 2020 Feb; 20(1):115. PubMed ID: 32054492
[TBL] [Abstract][Full Text] [Related]
3. Place of living at end-of-life according to cause of death: a comparative analysis of all decedents 70 years or older in 2009-2013 in Finland and Norway.
Bjørnelv GW; Aas E; Aaltonen M; Hagen TP; Thoresen L; Forma L
Ann Palliat Med; 2024 Apr; ():. PubMed ID: 38735697
[TBL] [Abstract][Full Text] [Related]
4. Describing settings of care in the last 100 days of life for cancer decedents: a population-based descriptive study.
Hafid A; Howard M; Webber C; Gayowsky A; Scott M; Jones A; Hsu AT; Tanuseputro P; Downar J; Conen K; Manuel D; Isenberg SR
Cancer Med; 2023 Feb; 12(4):4809-4820. PubMed ID: 36281530
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Site of Death, Health Care Utilization, and Hospital Expenditures for Patients Dying With Cancer in 7 Developed Countries.
Bekelman JE; Halpern SD; Blankart CR; Bynum JP; Cohen J; Fowler R; Kaasa S; Kwietniewski L; Melberg HO; Onwuteaka-Philipsen B; Oosterveld-Vlug M; Pring A; Schreyögg J; Ulrich CM; Verne J; Wunsch H; Emanuel EJ;
JAMA; 2016 Jan; 315(3):272-83. PubMed ID: 26784775
[TBL] [Abstract][Full Text] [Related]
6. Medical Costs and Healthcare Utilization among Cancer Decedents in the Last Year of Life in 2009.
Hwang I; Shin DW; Kang KH; Yang HK; Kim SY; Park JH
Cancer Res Treat; 2016 Jan; 48(1):365-75. PubMed ID: 25761472
[TBL] [Abstract][Full Text] [Related]
7. Health Care Utilization and Costs for Patients With End-Stage Liver Disease Are Significantly Higher at the End of Life Compared to Those of Other Decedents.
Kelly EM; James PD; Murthy S; Antonova L; Wong F; Shaw-Stiffel T; Chalifoux M; Salim M; Tanuseputro P
Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2339-2346.e1. PubMed ID: 30743007
[TBL] [Abstract][Full Text] [Related]
8. Escalating Health Care Expenditures in Cancer Decedents' Last Year of Life: A Decade of Evidence from a Retrospective Population-Based Cohort Study in Taiwan.
Hung YN; Liu TW; Wen FH; Chou WC; Tang ST
Oncologist; 2017 Apr; 22(4):460-469. PubMed ID: 28232596
[TBL] [Abstract][Full Text] [Related]
9. Rural/urban differences in health care utilization and place of death for persons with respiratory illness in the last year of life.
Goodridge D; Lawson J; Rennie D; Marciniuk D
Rural Remote Health; 2010; 10(2):1349. PubMed ID: 20438281
[TBL] [Abstract][Full Text] [Related]
10. Relating cause of death with place of care and healthcare costs in the last year of life for patients who died from cancer, chronic obstructive pulmonary disease, heart failure and dementia: A descriptive study using registry data.
van der Plas AG; Oosterveld-Vlug MG; Pasman HR; Onwuteaka-Philipsen BD
Palliat Med; 2017 Apr; 31(4):338-345. PubMed ID: 28056634
[TBL] [Abstract][Full Text] [Related]
11. Inpatient utilization and disparities: The last year of life of adolescent and young adult oncology patients in California.
Johnston EE; Alvarez E; Saynina O; Sanders LM; Bhatia S; Chamberlain LJ
Cancer; 2018 Apr; 124(8):1819-1827. PubMed ID: 29393967
[TBL] [Abstract][Full Text] [Related]
12. End-of-Life Health Care Utilization Between Chronic Obstructive Pulmonary Disease and Lung Cancer Patients.
Kuo LC; Chen JH; Lee CH; Tsai CW; Lin CC
J Pain Symptom Manage; 2019 May; 57(5):933-943. PubMed ID: 30708124
[TBL] [Abstract][Full Text] [Related]
13. Does Primary Care Model Effect Healthcare at the End of Life? A Population-Based Retrospective Cohort Study.
Howard M; Chalifoux M; Tanuseputro P
J Palliat Med; 2017 Apr; 20(4):344-351. PubMed ID: 27893954
[TBL] [Abstract][Full Text] [Related]
14. The healthcare costs of treating human papillomavirus-related cancers in Norway.
Hylin H; Thrane H; Pedersen K; Kristiansen IS; Burger EA
BMC Cancer; 2019 May; 19(1):426. PubMed ID: 31064346
[TBL] [Abstract][Full Text] [Related]
15. Dying with Parkinson's Disease: Healthcare Utilization and Costs in the Last Year of Life.
Zwicker J; Qureshi D; Talarico R; Webber C; Watt C; Kim W; Milani C; Ramanathan U; Mestre T; Tanuseputro P
J Parkinsons Dis; 2022; 12(7):2249-2259. PubMed ID: 36120791
[TBL] [Abstract][Full Text] [Related]
16. Rural-Urban Differences in Costs of End-of-Life Care for the Last 6 Months of Life Among Patients with Breast, Lung, or Colorectal Cancer.
Crouch E; Eberth JM; Probst JC; Bennett K; Adams SA
J Rural Health; 2019 Mar; 35(2):199-207. PubMed ID: 29656565
[TBL] [Abstract][Full Text] [Related]
17. Resource use, costs and quality of end-of-life care: observations in a cohort of elderly Australian cancer decedents.
Langton JM; Srasuebkul P; Reeve R; Parkinson B; Gu Y; Buckley NA; Haas M; Viney R; Pearson SA;
Implement Sci; 2015 Feb; 10():25. PubMed ID: 25884470
[TBL] [Abstract][Full Text] [Related]
18. Impact of home-visit nursing service use on costs in the last 3 months of life among older adults: A retrospective cohort study.
Sakano T; Anzai T; Takahashi K; Fukui S
J Nurs Scholarsh; 2024 Jan; 56(1):191-201. PubMed ID: 37642168
[TBL] [Abstract][Full Text] [Related]
19. Community-based specialist palliative care is associated with reduced hospital costs for people with non-cancer conditions during the last year of life.
Spilsbury K; Rosenwax L
BMC Palliat Care; 2017 Dec; 16(1):68. PubMed ID: 29216873
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
